SESSION 1: NEW METHODOLOGY AND EMERGING PARADIGMS FOR TOXICOLOGY RESEARCH

S1-1．Cross-sector replacement, reduction and refinement of acute toxicity tests

S1-2．Organoids and organ-on-a-chip in toxicology

SESSION 2: NEW TOXICANTS AND TARGETED ORGANS 

S2-1．Toxicity of opioids: new insights to understand and face the progressing threat

S2-2．Pesticide and herbicide exposure: from risk assessment to morbi-mortality reduction

S2-3．Assessing the exposure and toxicity of emerging toxicants in humans

S2-4．Advancements in reproductive toxicology

SESSION 3: TOXICOLOGICAL MECHANISM

S3-1．Mapping human immune development and new approach methodologies to test its vulnerability to toxicants

S3-2．Relevance of non-genotoxic mechanistic endpoints in different test systems for the evidence-based evaluation of carcinogenic hazards

S3-3．Environmental genotoxic effects: DNA damage response and cell death signaling

S3-4．RNA dysregulations and environmental carcinogenesis

SESSION 4: NANO AND PARTICULATE TOXICOLOGY

S4-1．Systemic and next generation toxic effects of inhaled carbonaceous ultrafine particles

S4-2．The serious issue of interference in nanotoxicology

S4-3．Airborne Micro- and Nanoplastics: Comprehensive Overview of Exposure, Toxicity and Risk Mitigation Strategies

S4-4．Air pollutants and PM2.5 - chemical composition and health consequences

S4-5．Frontiers in Environmental Toxicology on Emerging Pollutants

S4-6．Genetic toxicology, stem cell toxicology and nanotoxicology

SESSION 5: COMPUTATIONAL TOXICOLOGY, DATA SCIENCE AND AI

S5-1．Modernising approaches to safety assessment through use of in silico approaches in decision-making

S5-2．PARC- new approaches to model kinetic properties

S5-3．Towards next generation probabilistic risk assessment propelled by artificial intelligence and quantitative mode-of-action ontologies

S5-4．Thresholds of toxicological concern – recent developments across regions and at the interface with computational modelling

SESSION 6: CLINICAL AND DRUG TOXICOLOGY

S6-1．Toxicities from traditional pharmaceutical drugs: new insights into  the mechanisms and therapeutic approaches

S6-2．Mechanisms of immune system toxicity and therapeutic approaches for modifying disease

S6-3．Clinical translation and practice of hepatic toxicology

SESSION 7: SAFETY ASSESSMENT AND REGULATORY AFFAIRS

S7-1．Challenges and opportunities in translating microphysiological systems to regulatory decisions?

S7-2．The Westward Movement of Botanicals

S7-3．Safety assessments for dietary supplements and herbal products 

S7-4．The science, application and management in risk assessment

S7-5．Safety of recycled plastic for food packaging

S7-6．AI-Empowered environmental computational toxicology 

S7-7．Novel strategies for safety assessment: a paradigm shift for the future

S7-8．Next generation risk assessment

2．Drug toxicology and drug safety evaluation

3．Heavy metal toxicity and human health

4．Understanding and mitigating occupational heavy metal exposure: a comprehensive approach

5．High-throughput technology and health effects of heavy meatal

6．Joining forces towards the human exposome project

7．Strategic assessment and prioritization of chemicals for hazard and risk assessment

8．Unlocking the Future of Safety: New Approach Methodologies (NAMs) and Next Generation Risk Assessment (NGRA)

9．Gen AI in scientific publishing

10．Aquatic organisms as models for toxicity evaluation of emergent pollutants

11．Unique challenges and strategies for new modalities across bioanalytical, DMPK, toxicology, and regulatory affairs

1．Advancing scientific excellence and increasing confidence in NAMs through good In Vitro method practices (GIVIMP)

2．Episkin academy training

3．From the past to the present:does particle toxicology really change?

4．The emerging psychoactive drugs: epidemiology, consumption modes, and toxicities

5．Utilizing computational methods and tools for inferring and predicting reference dose (RfD) in chemical risk assessment

6．Advanced toxicological topics for study directors of nonclinical studies